BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22290959)

  • 1. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
    Warrier T; Tropis M; Werngren J; Diehl A; Gengenbacher M; Schlegel B; Schade M; Oschkinat H; Daffe M; Hoffner S; Eddine AN; Kaufmann SH
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1735-43. PubMed ID: 22290959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
    Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
    J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycolyltransferase from
    Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
    J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
    [No Abstract]   [Full Text] [Related]  

  • 4. I3-Ag85 effect on phthiodiolone dimycocerosate synthesis.
    Rens C; Laval F; Wattiez R; Lefèvre P; Dufrasne F; Daffé M; Fontaine V
    Tuberculosis (Edinb); 2018 Jan; 108():93-95. PubMed ID: 29523333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1
    Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
    D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
    Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
    Ronning DR; Klabunde T; Besra GS; Vissa VD; Belisle JT; Sacchettini JC
    Nat Struct Biol; 2000 Feb; 7(2):141-6. PubMed ID: 10655617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.
    Ibrahim DA; Boucau J; Lajiness DH; Veleti SK; Trabbic KR; Adams SS; Ronning DR; Sucheck SJ
    Bioconjug Chem; 2012 Dec; 23(12):2403-16. PubMed ID: 23190459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.
    Belisle JT; Vissa VD; Sievert T; Takayama K; Brennan PJ; Besra GS
    Science; 1997 May; 276(5317):1420-2. PubMed ID: 9162010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.
    Armitige LY; Jagannath C; Wanger AR; Norris SJ
    Infect Immun; 2000 Feb; 68(2):767-78. PubMed ID: 10639445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
    Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
    ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.
    Nguyen L; Chinnapapagari S; Thompson CJ
    J Bacteriol; 2005 Oct; 187(19):6603-11. PubMed ID: 16166521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity.
    Ronning DR; Vissa V; Besra GS; Belisle JT; Sacchettini JC
    J Biol Chem; 2004 Aug; 279(35):36771-7. PubMed ID: 15192106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
    Rao V; Gao F; Chen B; Jacobs WR; Glickman MS
    J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak spots inhibition in the
    Adewumi AT; Elrashedy A; Soremekun OS; Ajadi MB; Soliman MES
    J Biomol Struct Dyn; 2022 Apr; 40(7):2934-2954. PubMed ID: 33155529
    [No Abstract]   [Full Text] [Related]  

  • 18. Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex.
    Kuo CJ; Ptak CP; Hsieh CL; Akey BL; Chang YF
    J Biol Chem; 2013 Feb; 288(6):3886-96. PubMed ID: 23250738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and partial characterization of anti-cord factor (trehalose-6,6'-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium.
    Fujiwara N; Pan J; Enomoto K; Terano Y; Honda T; Yano I
    FEMS Immunol Med Microbiol; 1999 Jun; 24(2):141-9. PubMed ID: 10378413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.
    Kumar G; Dagur PK; Singh PK; Shankar H; Yadav VS; Katoch VM; Bajaj B; Gupta R; Sengupta U; Joshi B
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):57-65. PubMed ID: 20049651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.